Selected data models

You must log in to select data models for download or further analysis.

8 Search results.
Relevance Rating New first Old first

NI Sub SIRS MS University Hospital Muenster (UKM) Subform

- 11/24/16 - 1 form, 2 itemgroups, 16 items, 2 languages
Itemgroups: NI Sub SIRS, Criteria
Hospital Routine Documentation Subform at the University Hospital Muenster. Original Form name: NI Sub SIRS.

Collaborative Research Center | Transregio 240 (Sonderforschungsbereich Transregio 240) - Study specific blood sample and biobank (Studienspezifische Blutentnahme und Biobank)

- 10/1/20 - 1 form, 8 itemgroups, 40 items, 2 languages
Itemgroups: Administrative Data, Date, time and blood pressure at blood sample taking, Flow cytometry and aggregometry, Biobank, Biobank: EDTA wholeblood, Biobank: EDTA Plasma, Biobank: Citrat Plasma, Biobank: Serum
A central patient cohort within the interdisciplinary Collaborative Research Center / Transregio 240 aims to examine the role and function of platelets in different vascular diseases. For all patients enrolled in a CRC/TR240 cohorts (routine) blood markers are collected from the first blood draw.

A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904 - Session 3: Pharmacokinetics Blood

- 12/13/18 - 1 form, 20 itemgroups, 28 items, 1 language
Itemgroups: Administrative data, Dosing Date and Time, Predose, 30 Minutes, 45 Minutes, 1 Hour, 1.5 Hours, 2 Hours, 3 Hours, 4 Hours, 5 Hours, 6 Hours, 7 Hours, 8 Hours, 10 Hours, 12 Hours, 18 Hours, 24 Hours, 32 Hours, 48 Hours
Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904 - Session 2: Pharmacokinetics Blood

- 12/13/18 - 1 form, 20 itemgroups, 28 items, 1 language
Itemgroups: Administrative data, Dosing Date and Time, Predose, 30 Minutes, 45 Minutes, 1 Hour, 1.5 Hours, 2 Hours, 3 Hours, 4 Hours, 5 Hours, 6 Hours, 7 Hours, 8 Hours, 10 Hours, 12 Hours, 18 Hours, 24 Hours, 32 Hours, 48 Hours
Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904 - Session 4: Pharmacokinetics Blood

- 1/9/19 - 1 form, 20 itemgroups, 28 items, 1 language
Itemgroups: Administrative data, Dosing Date and Time, Predose, 30 Minutes, 45 Minutes, 1 Hour, 1.5 Hours, 2 Hours, 3 Hours, 4 Hours, 5 Hours, 6 Hours, 7 Hours, 8 Hours, 10 Hours, 12 Hours, 18 Hours, 24 Hours, 32 Hours, 48 Hours
Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

DZHK Data Catalogue - Biobanking Basic Set

- 10/10/19 - 1 form, 6 itemgroups, 29 items, 2 languages
Itemgroups: Number of aliquot tubes, Blood and Urine collection, Lab process steps, Sample properties (blood), Sample properties (urine), Comments
With permission from the DZHK administrative office. http://dzhk.de The DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.; German Center for Cardiovascular Research) is a joint cooperation of twenty-eight institutions in seven locations throughout Germany to develop a common research strategy. They developed a data catalogue with metadata and data as well as information about available biological materials from all their studies. For more information on the data catalogue and access to actual data and biosamples please visit https://dzhk.de/en/resources/data-manual/ . This version contains the metadata part only. The form Biobanking Basic Set is used to document the quality of samples of the Basic Set. The Basic Set consists of EDTA plasma, serum, citrate plasma, buffy coat and urine. The documentation is to be performed according to the DZHK's Biobanking SOPs, which can be accessed at https://dzhk.de/en/resources/sops/ (or https://dzhk.de/ressourcen/sops/ for the German language versions). The SOPs for this form are "Collection of Biomaterials from Blood and Urine" (version 1.1, valid as of 15/12/2014) and "Biomaterial Processing Basic Set" (version 1.1, valid as of 15/12/2014) for the English language versions, and "Gewinnung von Biomaterialien aus Blut und Urin" (version 1.1, valid as of 15/12/2014) and "Biomaterialverarbeitung Basis-Set" (versin 1.1, valid as of 15/12/2014) for the German language version. The collection of biomaterials is carried out in accordance with local regulations. Deviations from the following requirements will not result in the exclusion of the patient/test subject from the study. Collection of blood: Appropriate means of disposal for needles, swabs, etc. Period of rest in unaltered body position prior to blood collection: 5 minutes. Site of collection on patient/test subject: cubital vein. Tourniquet time < 1 minute. Specimens should be drawn in the following order: serum, citrate, EDTA. The tourniquet should be released once collection of blood has begun, i.e. when blood flow into the primary receptacle is visible. No repeat clenching of the fist. Invert immediately while exchanging the primary receptacles. Store the primary receptacles vertically in the primary receptacle/tube rack. Collection of urine: Label the urine cup using the sticker intended for that purpose. Inform the patient/test subject using the information sheet “Collecting a Mid-Stream UrineSpecimen”. Spontaneous urine collection. Immediately after urine specimen is given: document the time the urine specimen was collected and the appearance of the urine on the Biomaterial Collection Form. If patient/test subject is actively menstruating: Make a note of this on the Biomaterial Collection Form.

A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904 - Logs and Repeats: Vital Signs Form

- 1/11/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Administrative data, Vital Signs
Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

Supine Ankle-Arm Blood Pressure Cardiovascular Health Study (CHS)

- 7/15/16 - 1 form, 4 itemgroups, 22 items, 1 language
Itemgroups: Third Follow-up Supine Ankle-arm Blood Pressure Index, Pulse Obliteration Pressure, Systolic Readings, Date of interview
Documentation part: Record 15 Supine Anlke-Arm Blood Pressure The Cardiovascular Health Study (CHS) was initiated by the National Heart, Lung and Blood Institute (NHLBI) in 1987 to determine the risk factors for development and progression of cardiovascular disease (CVD) in older adults, with an emphasis on subclinical measures. The study recruited 5,888 adults aged 65 or older at entry in four U.S. communities and conducted extensive annual clinical exams between 1989-1999 along with semi-annual phone calls, events adjudication, and subsequent data analyses and publications. Additional data were collected by studies ancillary to CHS. With the exception of annual clinic visits, these activities are still ongoing. Data obtained from: https://chs-nhlbi.org/ Permission granted by: Erika Enright.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial